Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01553942
Title Afatinib With CT and RT for EGFR-Mutant NSCLC
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

lung non-small cell carcinoma

Therapies

Afatinib

Cisplatin

Pemetrexed Disodium

Age Groups: adult
Covered Countries USA


No variant requirements are available.